The effects of cAMP on cell growth and proliferation have been intensely investigated, but its mechanisms of action are not completely understood. The effects of cAMP are predominantly mediated by the cAMP-dependent protein kinase (PKA), which is composed of two distinct subunits, catalytic (C) and regulatory (R), forming a tetrameric holoenzymes, R2C2. The type I regulatory alpha (RIalpha) subunit expression is associated with hyperproliferation in human breast tissue and its overexpression in human breast cancer correlates with malignancy and poor prognosis. Increased expression of RI? stimulates growth, whereas overexpression of the C subunit does not produce such consequence. Most recently, RIalpha was shown to be a tumor suppressor gene in Carney Complex Syndrome. We have demonstrated previously novel interaction of RIalpha that is independent of the C subunit kinase activity. In this application, we show by yeast two-hybrid interaction cloning experiment that RIalpha associates with a novel BTB/POZ domain zinc finger transcription factor, termed RIalpha-associated zinc finger protein (RIAZ). We demonstrate that RIAZ is a cAMP-responsive transcriptional activator regulated by its interaction with RIalpha and potential cooperation with the cAMP-response element binding protein (CREB). We show further that RIAZ is aberrantly expressed in approximately 15% of human primary breast cancer. Furthermore, overexpression of RIAZ causes growth inhibition measured by [3H]thymidine uptake. The growth inhibition is enhanced by cAMP but not affected by the PKA inhibitor H-89. We hypothesize that RI? interaction with RIAZ may be a novel transcriptional mechanism in growth inhibition transduced by cAMP. In this proposal, we will: (1) determine the mechanisms of RI? interaction with RIAZ and regulation by cAMP; (2) investigate the mechanisms of RIAZ transcriptional response to cAMP; and (3) investigate the mechanisms of growth control by RI? interaction with RIAZ in response to cAMP. Our results will shed light on this novel interaction of RIalpha with RIAZ in growth inhibition.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA102204-01A2
Application #
6923543
Study Section
Tumor Cell Biology Study Section (TCB)
Program Officer
Ault, Grace S
Project Start
2005-08-10
Project End
2010-05-31
Budget Start
2005-08-10
Budget End
2006-05-31
Support Year
1
Fiscal Year
2005
Total Cost
$223,192
Indirect Cost
Name
University of Toledo
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Szkudlarek-Mikho, Maria; Saunders, Rudel A; Yap, Sook Fan et al. (2012) Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis. Biochem Biophys Res Commun 428:487-93
Saunders, Rudel A; Fujii, Kazuyuki; Alabanza, Leah et al. (2010) Altered phospholipid transfer protein gene expression and serum lipid profile by topotecan. Biochem Pharmacol 80:362-9
Wu, Qiong; Saunders, Rudel A; Szkudlarek-Mikho, Maria et al. (2010) The obesity-associated Fto gene is a transcriptional coactivator. Biochem Biophys Res Commun 401:390-5
Yang, Weng-Lang; Ravatn, Roald; Kudoh, Kazuya et al. (2010) Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278). Biochem Biophys Res Commun 391:1318-23
Kablan, Ahmed; Saunders, Rudel A; Szkudlarek-Mikho, Maria et al. (2010) Prieurianin Causes Weight Loss in Diet-Induced Obese Mice and Inhibits Adipogenesis in Cultured Preadipocytes. J Diabetes Metab 1:
Szkudlarek, Maria; Bosio, Rual M; Wu, Qiong et al. (2009) Inhibition of angiogenesis by extracellular protein kinase A. Cancer Lett 283:68-73